Delta Lloyd’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | $6.38M | Buy |
23,503
+1,815
| +8% | +$493K | 0.18% | 134 |
|
|
2017
Q1 | $5.93M | Sell |
21,688
-337
| -2% | -$92.1K | 0.18% | 136 |
|
|
2016
Q4 | $6.25M | Buy |
22,025
+4,651
| +27% | +$1.32M | 0.2% | 136 |
|
|
2016
Q3 | $5.44M | Buy |
17,374
+1,501
| +9% | +$470K | 0.17% | 115 |
|
|
2016
Q2 | $3.84M | Sell |
15,873
-1,076
| -6% | -$260K | 0.13% | 131 |
|
|
2016
Q1 | $4.41M | Sell |
16,949
-1,901
| -10% | -$495K | 0.15% | 125 |
|
|
2015
Q4 | $5.78M | Buy |
18,850
+1,150
| +6% | +$352K | 0.2% | 93 |
|
|
2015
Q3 | $5.17M | Buy |
17,700
+1,427
| +9% | +$416K | 0.17% | 124 |
|
|
2015
Q2 | $6.57M | Buy |
16,273
+6,064
| +59% | +$2.45M | 0.2% | 109 |
|
|
2015
Q1 | $4.31M | Sell |
10,209
-579
| -5% | -$244K | 0.13% | 113 |
|
|
2014
Q4 | $3.66M | Buy |
10,788
+719
| +7% | +$244K | 0.11% | 127 |
|
|
2014
Q3 | $3.33M | Buy |
10,069
+559
| +6% | +$185K | 0.03% | 129 |
|
|
2014
Q2 | $3M | Buy |
9,510
+1,162
| +14% | +$366K | 0.09% | 129 |
|
|
2014
Q1 | $2.55M | Buy |
8,348
+661
| +9% | +$202K | 0.09% | 127 |
|
|
2013
Q4 | $2.15M | Sell |
7,687
-27,483
| -78% | -$7.68M | 0.08% | 148 |
|
|
2013
Q3 | $8.47M | Sell |
35,170
-8,321
| -19% | -$2M | 0.33% | 65 |
|
|
2013
Q2 | $9.36M | Buy |
+43,491
| New | +$9.36M | 0.36% | 57 |
|